1. Sanofi, despite the pandemic, sees early gains from CEO Hudson's strategy — Trump administration to require insurers to cover COVID-19 vaccine — Regeneron/Sanofi's Libtayo gets priority review in NSCLC — See more on our front page news Stay updated with the latest pharma-related coronavirus news on our new page
    Dismiss Notice
  2. Please take our quick survey on how COVID-19 is impacting your job It will only take a minute or two to respond. The survey is confidential, and does not require registration. Thank you in advance for your participation. We will provide regular updates on results as responses accumulate.
    Dismiss Notice


  1. anonymous
  2. anonymous
  3. anonymous
  4. anonymous
  5. anonymous
  6. anonymous
  7. anonymous
  8. anonymous
  9. anonymous
  10. anonymous
  11. anonymous
  12. anonymous
  13. anonymous
  14. anonymous
  15. anonymous
  16. anonymous
  17. anonymous
  18. anonymous
  19. anonymous
  20. Anon News Reader